Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

Particle Formation and

Vaccination and 30-Day

Honor Was Never Lost:

Annamalai, Arun Sarava

Intravenous and Intrap

See All (8) pages

Contact Us
If you have any questions or feedback please contact us.

Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients.

Van Matre ET, Teitelbaum I, Kiser TH. Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients. Antimicrob Agents Chemother. 2020 04 21; 64(5).

View in: PubMed

subject areas

Anti-Bacterial Agents
Ascitic Fluid
Cross-Over Studies
Female
Gram-Positive Bacteria
Gram-Positive Bacterial Infections
Humans
Kidney Failure, Chronic
Male
Microbial Sensitivity Tests
Middle Aged
Peritoneal Dialysis
Peritonitis
Prospective Studies
Teicoplanin

authors with profiles

Ty Heath Kiser

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium